Get started
Author

Alicia García Dorta

Observed names: A Dorta, A. García Dorta, Alicia Garcia Dorta, Alicia Garcia-Dorta, Alicia García-Dorta
ORCID: 0000-0003-1820-9630
Observed ORCID: 0000-0003-1820-9630
OpenAlex ID: A5085450697
Association of Gender, Diagnosis, and Obesity With Retention Rate of Secukinumab in Spondyloarthropathies: Results Form a Multicenter Real-World Study
2022 · Alicia García-Dorta, Paola León-Suarez, et al. · Frontiers in Medicine · 26
PDF
Epidemiological and genetic features of anti-3‑hydroxy-3-methylglutaryl-CoA reductase necrotizing myopathy: Single-center experience and literature review
2022 · Diana Prieto-Peña, Javier G. Ocejo-Vinyals, et al. · European Journal of Internal Medicine · 18
Visual manifestations in giant cell arteritis: identification of risk factors from the ARTESER Registry
2024 · Juan Molina-Collada, Marta Domínguez-Álvaro, et al. · Rheumatology · 16
Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study
2023 · José M Álvaro-Gracia, Carlos Sanchez-Piedra, et al. · RMD Open · 14
PDF
VEXAS syndrome through a rheumatologist’s lens: insights from a Spanish national cohort
2025 · Paula García-Escudero, Marta López-Gómez, et al. · Rheumatology · 13
Beta-cell function is disrupted in patients with systemic lupus erythematosus
2020 · Alicia García-Dorta, Juan Carlos Quevedo-Abeledo, et al. · Rheumatology · 12
The Number of Traditional Cardiovascular Risk Factors Is Independently Correlated with Disease Activity in Patients with Psoriatic Arthritis
2020 · Iván Ferraz-Amaro, Diana Prieto-Peña, et al. · Medicina · 11
PDF
Sex differences among patients with giant cell arteritis: insights from the Spanish ARTESER Registry
2025 · Delia Fernández-Lozano, Marta Domínguez-Álvaro, et al. · Rheumatology · 5
Cancer risk in patients with rheumatoid arthritis receiving biologic and targeted synthetic disease-modifying antirheumatic drugs: results from the BIOBADASER III registry
2025 · Juan Molina-Collada, Lucía Otero-Varela, et al. · Rheumatology · 5
Baseline Levels of Vitamin D in a Healthy Population from a Region with High Solar Irradiation
2021 · Alicia García-Dorta, Lillian Medina-Vega, et al. · Nutrients · 4
PDF
Multicenter Study of Secukinumab Uptitration in Axial Spondyloarthritis: Real-World Evidence
2025 · Dalifer Freites Núñez, Adela Gallego, et al. · The Journal of Rheumatology · 3
Can Vitamin D Reduce Glucocorticoid-Induced Adverse Effects in Patients with Giant Cell Arteritis? Results from 1568 Patients in the Spanish ARTESER Registry
2025 · Gastón A. Ghio, Marta Domínguez-Álvaro, et al. · Nutrients · 2
PDF
Mortality in patients with giant cell arteritis in Spain: results from the ARTESER registry
2025 · Juan Molina-Collada, Marta Domínguez-Álvaro, et al. · Arthritis Research & Therapy · 2
PDF
Pos1073 Impact of Comorbidities on the First Bdmard Effectiveness and Retention Rate After 2 Years of Follow-up in Patients With Rheumatoid Arthritis. Data From the Spanish Registry Biobadaser
2023 · J. Calvo Gutierrez, C. López-Medina, et al. · Annals of the Rheumatic Diseases · 1
PDF
Risk of new primary cancer, locoregional progression or metastasis associated with bDMARDs and tsDMARDs in patients with rheumatoid arthritis and prior cancer: insights from the ARCA registry
2026 · Juan Molina-Collada, Chamaida Plasencia-Rodriguez, et al. · RMD Open
PDF
Pos0955 Characterization of Patients With Polymyalgia Rheumatica in the Arteser Giant Cell Arteritis Registry
2025 · M. Silva-Díaz, M. Dominguez-Alvaro, et al. · Annals of the Rheumatic Diseases
Abs0081 Retrospective Observational Study of Obstetric Outcomes in Patients With Undifferentiated Connective Tissue Disease Compared to Systemic Lupus Erythematosus: a Multicenter Study
2025 · A. García Dorta, C. Oramas Marco, et al. · Annals of the Rheumatic Diseases
Pos1116 Vexas Syndrome in Rheumatology: 47 Cases From Vexasser Study Group
2025 · P. García-Escudero, M. López I Gómez, et al. · Annals of the Rheumatic Diseases
Abs0947 the Impact of Cancer on the Management of Rheumatoid Arthritis: Insights From the Arca Registry
2025 · J. Molina-Collada, C. Plasencia-Rodríguez, et al. · Annals of the Rheumatic Diseases
Pos0134 Acr/eular 2022 Classification Criteria Compared to the Acr 1990 Classification Criteria in the Arteser Registry of Giant Cell Arteritis
2025 · E. De Miguel, M. Dominguez-Alvaro, et al. · Annals of the Rheumatic Diseases
Pos1281 Implementation of an Electronic Patient-reported Outcome Measures System for Remote Monitoring in Biobadaser: a Multicenter Registry of Advanced Therapies in Rheumatology
2025 · I. Castrejon, L. Otero-Varela, et al. · Annals of the Rheumatic Diseases
POS0473 Discontinuation Pattern of Glucocorticoids in Patients with Rheumatoid Arthritis initiating biologics or targeted synthetic DMARDs in routine care: real-world data from BIOBADASER
2025 · I. Castrejon, L. Otero-Varela, et al. · Annals of the Rheumatic Diseases
Management of ventricular septal defect. an unsolved problem
2025 · F Sansegundo Burgueno, A Dorta, et al. · European Heart Journal Acute Cardiovascular Care
PDF
Measure and achievable of quality indicators in an out-of-hospital cardiac arrest real population
2025 · A Dorta, F Sansegundo Burgueno, et al. · European Heart Journal Acute Cardiovascular Care
PDF
Pos0670 Pattern of Use of Glucocorticoids in Patients With Rheumatoid Arthritis Initiating Biologics or Targeted Synthetic Therapies in Real Life: Data From Biobadaser
2024 · I. Castrejon, L. Otero-Varela, et al. · Annals of the Rheumatic Diseases
Works count: 35
Citation count: 132
H-index: 7
I10-index: 7
Year
Topic
Type